The Economics of Diabetes Mellitus:
An Annotated Bibliography
Historical
This webpage is archived for historical purposes and is no longer being maintained or updated.
The numbers in this index refer to abstract numbers rather than to page numbers.
Index of Titles
A B C D E F G H I L M N O P Q R S T U V WAccess to Coverage: Health Insurance for People With Diabetes. 253
ACE Inhibition in Diabetic Patients: Economic Implications. 158
Adherence to Treatment and Social Support in Patients with Non-Insulin Dependent Diabetes. 13
Ambulatory Medical Care for Diabetes. 254
Ambulatory Nutrition Care: Adults-Diabetes Mellitus. 255
American Diabetes Association Annual Meeting 1996: Managed Care and Change in Medicine. 227
Amputation in the Diabetic Population: Incidence, Causes, Cost, Treatment, and Prevention. 256
Amputations in the Surgical Budget. 139
Amputations in the Surgical Budget (letter). 140
Analysis of Direct Cost of Standard Compared with Intensive Insulin Treatment of Insulin-Dependent Diabetes Mellitus and Cost of Complications. 14
Applying Recent Findings to Clinical Care in Type II Diabetes. 257
Assessing the Costs and Benefits of Medical Research: The Retinopathy Study. 258
Assessment of the Effect of a Comprehensive Diabetes Management Program on Hospital Admission Rates of Children with Diabetes Mellitus. 15
Audit in General Practice by a Receptionist: A Feasibility Study. 16
Bedside Blood Sugar Determinations in the Critically Ill. 17
Benefits of Prevention: The Medicare Therapeutic Shoe Demonstration. 107
Budget Trends and Issues Affecting Biomedical Research: A Perspective From the National Institute of Diabetes and Digestive and Kidney Diseases. 229
The Burden of Diabetes in North Carolina. 192
The Burden of Diabetes: The Cost of Diabetes Hospitalizations in Wisconsin, 1994. 141
Capillary Blood Glucose Screening for Gestational Diabetes: A Preliminary Investigation. 120
Capillary Glucose Determination in the Screening of Gestational Diabetes. 121
Cardiovascular Complications of Diabetes Mellitus: What We Know and What We Need to Know About Their Prevention. 259
Cardiovascular Morbidity and Mortality in Type 2 Diabetic Patients: A 22-Year Historical Cohort Study in Dutch General Practice. 18
Care of the Diabetic Child in the Community. 19
Case Management and Quality of Care for Diabetic Patients. 260
CDC Diabetes Control Programs — Overview of Diabetes Patient Education. 230
The Charges for ESRD Treatment of Diabetics. 176
Clinical Economics: A Guide to the Economic Analysis of Clinical Practices. 261
Clinical Experience with a Screening Program for Gestational Diabetes. 122
Clinical Features and Health-Care Costs of Diabetic Nephropathy. 142
A Clinician's Guide to Cost-Effective Analysis. 262
Closing the Gap: The Problem of Diabetes Mellitus in the United States. 159
A Comparison of Accuracy and Estimated Cost of Methods for Home Blood Glucose Monitoring. 20
Comparison of Different Models of Diabetes Care on Compliance with Self-Monitoring of Blood Glucose by Memory Glucometer. 21
Comparison of Five Glucose Meters for Self-Monitoring of Blood Glucose by Diabetic Patients. 52
Comparison of Glycosylated Hemoglobin and Fasting Plasma Glucose with Two-Hour Post-Load Plasma Glucose in the Detection of Diabetes Mellitus. 3
Comparison of Screening Tests for Non-Insulin-Dependent Diabetes Mellitus. 4
Conference Report: Approaches to the Treatment of Type II Diabetes and Developments in Glucose Monitoring and Insulin Administration. 53
Continuous Quality Improvement Can Improve Glycemic Control for HMO Patients with Diabetes. 22
Conversion from Glipizide to Glyburide: A Prospective Cost-Impact Survey. 168
Cost Analysis of Kidney-Pancreas and Kidney-Islet Transplant. 92
Cost-Benefit Analysis of Diabetic Eye Disease. 66
Cost-Benefit Analysis of Preconception Care for Women with Established Diabetes Mellitus. 134
Cost-Benefit Analysis of Preconception Care for Women with Established Diabetes Mellitus. Final Report. 135
A Cost-Benefit Analysis of Subcutaneous Insulin Pump Infusion Therapy for Insulin-Dependent Diabetes Mellitus. 23
Cost Concepts for Diabetes Educators: An Introduction. 263
Cost-Effective Approach to Office Screening for Gestational Diabetes. 125
Cost-Effective Criteria for Glucose Screening. 126
Cost-Effective Screening for Retinopathy Using a Nonmydriatic Retinal Camera in a Prepaid Health-Care Setting. 67
Cost-Effective Treatment for Diabetic End-Stage Renal Disease: Dialysis, Kidney, or Kidney-Pancreas Transplantation? 94
Cost-Effectiveness Analyses of the Conversion of Patients With Non-Insulin-Dependent Diabetes Mellitus from Glipizide to Glyburide and of the Accompanying Pharmacy Follow-up Clinic. 24
Cost-Effectiveness Modeling of Simultaneous Pancreas-Kidney Transplantation. 95
Cost-Effectiveness of Alternative Methods for Retinopathy Screening. 68, 69
Cost-Effectiveness of Current Approaches to the Control of Retinopathy in Type I Diabetics. 70
Cost-Effectiveness of Detecting and Treating Retinopathy. 71
Cost-Effectiveness of Diabetes Education. 265
Cost-Effectiveness of Early Digit Amputation in the Patient With Diabetes. 108
Cost-Effectiveness of Medical Nutrition Therapy Provided by Dietitians for Persons with Non-Insulin- Dependent Diabetes Mellitus. 48
The Cost-Effectiveness of Preventive Care for Diabetes Mellitus. 266
Cost-Effectiveness of Screening and Early Treatment of Nephropathy in Patients with Insulin-Dependent Diabetes Mellitus. 96
Cost-Effectiveness of Strategies for Detecting Retinopathy. 72
Cost-Effectiveness of the Screening and Treatment of Retinopathy. What Are the Costs of Underutilization? 73
Cost-Effectiveness Study of a Lipid-Lowering Therapy in Hyperlipoproteinaemia Type IIb and Type IV (Frederickson). 25
Cost Efficacy of Routine Screening for Diabetes in Pregnancy: 1-h Versus 2-h Specimen. 123
The Cost of Diabetes. 193
Cost of Diabetes Care. 264
Cost of Diabetes in France. 194
The Cost of Diabetic Foot Problems. 196
The Cost of Diabetic Neuropathy. 197
The Cost of Education (Editorial). 198
The Cost of Hospitalization for the Late Complications of Diabetes in the United States. 143
The Cost of Immunosuppression and Coverage of Immunosuppressive Drugs for Kidney Transplant Recipients Under the Medicare Catastrophic Coverage Act. 93
The Cost of Insulin-Dependent Diabetes Mellitus (IDDM) in England and Wales. 199
Cost of Non-Insulin-Dependent Diabetes in Women with a History of Gestational Diabetes: Implications for Prevention. 124
The Cost of Obesity: The US Perspective. 200
Cost Savings Associated with Detection and Treatment of Diabetic Eye Disease. 65
The Costs And Effects of Two Different Lipid Intervention Programmes in Primary Health Care. 26
The Costs of Diabetes and Its Complications. 267
Costs of Diabetes in Texas, 1992. 195
The Costs of Diabetes-Related Lower Extremity Amputations in the Netherlands. 144
Costs of Insulin-Dependent Diabetes Mellitus. 201
The Costs of Nephropathy in Type II Diabetes. 97
Costs of Temporary and Permanent Disability Induced by Diabetes. 202
Counting the Cost of Diabetic Hospital Admissions From a Multi-Ethnic Population in Trinidad. 145
Coverage of Diabetes Education Programs. 231
Detecting and Treating Retinopathy in Patients with Type I Diabetes Mellitus: A Health Policy Model. 74
Detecting and Treating Retinopathy in Patients with Type I Diabetes Mellitus: Savings Associated with Improved Implementation of Current Guidelines. 75
Detection of Sight-Threatening Diabetic Eye Disease. 76
The Development of Community Orientated Recommendations for Diabetes Care in South Auckland. 27
Diabetes. 203
Diabetes and Long-Term Care. 177
Diabetes Care in a UK Health Region: Activity, Facilities and Costs. 204
Diabetes Care in Health Maintenance Organizations. 268
The Diabetes Education Study: A Controlled Trial of the Effects of Diabetes Patient Education. 54
Diabetes Guidelines, Outcomes, and Cost-Effectiveness Study: A Protocol, Prototype, and Paradigm. 269
Diabetes, Health Insurance, and Health-Care Reform. 270
Diabetes in a Managed Care System. 271
Diabetes in Urban African Americans: III. Management of Type II Diabetes in a Municipal Hospital Setting. 28
Diabetes — Inpatient Utilisation, Costs and Data Validity: Dunedin 1985-9. 146
Diabetes Mellitus and the St. Vincent Declaration: The Economic Implications. 272
Diabetes Mellitus in Egypt. 205
Diabetes Outpatient Education: The Evidence of Cost Savings. 232
Diabetes Patient Education Programs: Quality and Reimbursement. 273
Diabetes-Related Hospitalization and Hospital Utilization. 147
Diabetes — The Cost of Illness and the Cost of Control: An Estimate for Sweden 1978. 206
Diabetic Dyslipidemia: A Case for Aggressive Intervention in the Absence of Clinical Trial and Cost- effectiveness Data. 274
Diabetic Foot Care: Financial Implications and Practice Guidelines. 109
Diabetic Foot Ulcers in a Multidisciplinary Setting: An Economic Analysis of Primary Healing and Healing With Amputation. 110
Diabetic Ketoacidosis Charges Relative to Medical Charges of Adult Patients with Type 1 Diabetes. 178
Diabetic Ketoacidosis Costs Relative to Medical Costs of Patients with Type 1 Diabetes [abstract]. 179
Diagnosis Related Groups, Resource Utilization, Age, and Outcome for Hospitalized Nephrology Patients. 148
Digging Out Savings in Diabetes Care: Costing Out Care. 180
Direct and Indirect Costs of Cardiovascular and Cerebrovascular Complications of Type II Diabetes. 207
Direct and Indirect Costs of Diabetes in Minnesota in 1988. 208
Direct and Indirect Costs of Diabetes in the United States in 1987. 209
Direct and Indirect Costs of Diabetes in the United States in 1992. 210
Direct Costs of Diabetes Care: A Survey in Ottawa, Ontario 1986. 160
Drug Consumption in Elderly Diabetics. 169
Economic Analysis of Captopril in the Treatment of Diabetic Nephropathy. 98
Economic Consequences of Diabetes Mellitus in the U.S. in 1997. 211
Economic Cost of Diabetes Mellitus: Minnesota, 1988. 212
The Economic Cost of Obesity: The French Situation. 213
Economic Costs of Diabetes. 275
The Economic Costs of Non-Insulin-Dependent Diabetes Mellitus. 214
Economic Costs of Obesity. 215
The Economic Costs of NIDDM. 276
Economic Evaluation of the Contribution of Captopril in the Treatment of Diabetic Nephropathy: A Cost- Effectiveness Approach. 99
Economic Evaluations of Type II Diabetes. 216
Economic Impact of Diabetes. 217, 218
Economic Impact of Diabetes Mellitus in the Elderly. 181
Economic Impact of Type II Diabetes Mellitus. 219
Economic Implications of IGT Intervention: The Case of a "Phantom Alternative"? 277
The Economics of Pharmacotherapy for Diabetes Mellitus. 170
The Economics of Screening for Microalbuminuria in Patients with Insulin-Dependent Diabetes Mellitus. 161 "Educating" the Person With Diabetes in an Ambulatory Setting. 162
Effect of Diabetes Education on Self-Care Metabolic Control and Emotional Well-Being. 55, 56
Effect of Third Party Reimbursement on the Utilization of Services and Indices of Diabetes Management Among Inner City Diabetic Patients. 182
Effect of Value-Added Utilities on Prescription Refill Compliance and Medicaid Health Care Expenditures: A Study of Patients with Non-Insulin-Dependent Diabetes Mellitus. 29
The Effectiveness of Diabetes Education for Non-Insulin-Dependent Diabetic Persons. 57
Effectiveness of Glycosylated Hemoglobin, Fasting Plasma Glucose, and a Single Post Load Plasma Glucose Level in Population Screening for Glucose Intolerance. 5 Effectiveness of Screening for Diabetes. 1
Effects of Diet and Exercise Interventions on Control and Quality of Life in Non-Insulin-Dependent Diabetes. 49
Effects of Educational Interventions in Diabetes Care: A Meta-Analysis of Findings. 58
Efficacy of Insulin and Sulfonylurea Combination Therapy in Type II Diabetes. A Meta-Analysis of the Randomized Placebo-Controlled Trials. 30.Emotional Side Effects of Diabetes Educational Program (letter; comment). 278
Employment, Work Disability, and Income Support Program Participation. 100
Estimating the Impact of Total Illness Burden on Patient Outcomes Among Patients with Non-Insulin Dependent Diabetes: A Comparison of Three Co-Morbidity Measures (abstract). 279
Evaluating the Costs and Benefits of Outpatient Diabetes Education and Nutrition Counseling. 59
Evaluation of a Practice-Based Programme of Health Checks: Financial Cost and Success at Risk Detection. 31
Evaluation of a Structured Treatment and Teaching Program for Non-Insulin-Treated Type II Diabetic Outpatients in Germany After the Nationwide Introduction of Reimbursement Policy for Physicians. 60
Evaluation of Argon Laser Treatment of Retinopathy and Its Diffusion in The Netherlands. 77
The Evaluation of Mobile Screening for Retinopathy. 78
Evaluation of the Costs to Medicare of Covering Therapeutic Shoes for Diabetic Patients. 111
Evaluative Approaches to Type II Diabetes. 233
The Feasibility of a Potentially "Ideal" System of Integrated Diabetes Care and Education Based on a Day Centre. 32
Financial Implications of Implementing Standards of Care for Diabetes and Pregnancy. 136
Financial Implications of Implementing Standards of Care for Diabetic Eye Disease. 280
Financing the Care of Diabetes Mellitus in the U.S.: Background, Problems, and Challenges. 220
First Prenatal Visit Glucose Screening. 127
The First Two Years of Type I Diabetes in Children: Length of the Initial Hospital Stay Affects Costs but Not Effectiveness of Care. 149
Foot Infections in Diabetic Patients: Decision and Cost-Effectiveness Analyses. 112
Fructosamine or Glycated Haemoglobin as a Measure of Diabetic Control? 33
The Glycosylated Hemoglobin as a Diagnostic and Monitoring Tool for Diabetes: Evidence from Claims Data (abstract). 6
The Health Belief Model and Adolescents with Insulin-Dependent Diabetes Mellitus. 281
Health Care Expenditures for People with Diabetes Mellitus, 1992. 183
Health Insurance and the Financial Impact of IDDM in Families with a Child with IDDM. 163
Health-Insurance Coverage for Adults with Diabetes in the U.S. Population. 282
Hospital Charges. 101
Hospital Costs, Use of Resources, and Dynamics of Death Associated with Diabetes Mellitus. 164
Hospitalization and Expenditures for the Treatment of General Medical Conditions Among the U.S. Diabetic Population in 1991. 150
Hospitals Adopt Intensive Programs for Diabetic Patients to Avoid High Inpatient Costs. 151
Hypoglycemic Drugs in the Treatment of Non Insulin Dependent Diabetes Mellitus (NIDDM) in Klong Toey Slum (abstract). 171
Immunization to Prevent Insulin-dependent Diabetes Mellitus? The Economics of Genetic Screening and Vaccination for Diabetes. 7
Importance of Outpatient Supervision in the Prognosis of Juvenile Diabetes Mellitus: A Cost/Benefit Analysis. 34
Improving the Financing of Diabetes Care in the 1990's: Recommendations of the 1989 Conference. 234
The Indirect Costs of Morbidity in Type II Diabetic Patients. 221
Inpatient or Outpatient Initiation of Insulin Therapy: Experience and Cost Effective Analysis in a Suboptimal Clinical Setting. 35
Insulin-Glyburide Combination Therapy for Non-Insulin-Dependent Diabetes Mellitus: A Long-Term Double- Blind, Placebo-Controlled Trial. 37
Insulin Injection Technique Can Be Taught Without Hospitalization. 36
Insurance Coverage for People with Diabetes: Third party Reimbursement for Diabetes Education and Technologies. 283
Intensive Ambulatory Treatment of Insulin-Dependent Diabetes. 284
Intensive Insulin Therapy: Part I. Basic Principles. 285
Intensive Insulin Therapy: Part II. Multicomponent Insulin Regimens. 286
Is Glycohemoglobin Testing Useful in Diabetes Mellitus? Lessons from the Diabetes Control and Complications Trial. 287
Is Screening and Intervention for Microalbuminuria Worthwhile in Patients With Insulin Dependent Diabetes? 102
Labour Productivity Effects of Prescribed Medicines for Chronically Ill Workers. 172
Less Expensive, Reliable Blood Glucose Self-Monitoring. 38
Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial. 39
Local Survey of Optometrists about Dilated Funduscopic Examinations for Patients with Diabetes: Making Use of Phone Book Yellow-Page Listings. 79
Long-Term Costs for Foot Ulcers in Diabetic Patients in a Multidisciplinary Setting. 113
Managed Care Approaches to Diabetes Mellitus. 288
Management of Patients with Diabetes by Nurses with Support of Subspecialists. 40
Medical and Financial Implications of Discontinuing a Statewide Free Insulin Program Involving 3,720 People. 165
Medical Expenditures and Insurance Coverage for People with Diabetes: Estimates from the National Medical Care Expenditure Survey. 184
Medical Technology and Costs of the Medicare Program. 235
Medicare Admission Criteria for Diabetes Mellitus in Florida. 289
Medicare Supplement Plan Required to Cover Diabetes. 228
Medicare Therapeutic Shoe Demonstration: Report to Congress. 114
Medicare Therapeutic Shoes Demonstration: Was the Demonstration Cost Effective? Final Comprehensive Report, Volume I. 115
Medication Cost Savings Associated with Weight Loss for Obese Non-Insulin-Dependent Diabetic Men and Women. 173
Meeting the Challenge of Diabetic Blindness in the 90's. 80
Meeting the Needs of the Economically Deprived Diabetic. 290
Mobile Retinal Photography: A Means of Screening for Retinopathy in Aboriginal Communities. 81
Money Matters: Should Ability to Pay Ever Be a Consideration in Gaining Access to Transplantation? 291
Multiple Biochemical Blood Testing as a Case-Finding Tool in Ambulatory Medical Patients. 8
Must Diabetes Be a Fatal Disease in Africa? Study of Costs of Treatment. 185
The National Long-Range Plan to Combat Diabetes, 1987. 236
National Standards and Review Criteria for Diabetes Patient Education Programs: Quality Assurance for Diabetes Patient Education. 237
New Approaches to Medical Technology Coverage: Conference Proceedings. 238
New Mexicare. 292
Nurses' Perceptions: Issues that Arise in Caring for Patients with Diabetes in a Managed Care Environment (abstract). 293
Nursing Case Management: An Innovative Model of Care for Hospitalized Patients with Diabetes. 41
Obesity and the U.S. Navy [letter]. 61
Office Visits for Diabetes Mellitus: United States, 1989. 239
Operations, Total Hospital Stay and Costs of Critical Leg Ischemia. A Population-Based Longitudinal Outcome Study of 321 Patients. 152
Ophthalmic Screening for Diabetics: The Importance of Physician-Ophthalmologist Collaboration in the Prevention of Blindness. 82
Opportunities for Cost Reduction in Retinopathy Treatment: Case Study From Mexico. 83 Optometrist Screening for Retinopathy: Evidence and Environment. 294
Oral Hypoglycemic Agents in the Treatment of Type II Diabetes. 174
Osteomyelitis in Feet of Diabetics: Clinical Accuracy, Surgical Utility, and Cost-Effectiveness of MR Imaging. 116
An Outpatient-Focused Program for Childhood Diabetes: Design, Implementation, and Effectiveness. 166
Pancreas Transplantation as a Treatment for Diabetes: Indications and Outcome. 103
Pancreas Transplantation for Type I Diabetes Mellitus: Do the Benefits Offset the Risks and Cost? 295
Patient Education Financing Under Medicare. 296
Patterns of Hospitalization in a Pediatric Diabetes Clinic in Sydney. 153
Paying for Preventive Care: Moving the Debate Forward. 297
Payment for Diabetes Care Under the Medicare Fee Schedule. 298
Perceived Effectiveness, Cost, and Availability of Patient Education Methods and Materials. 299
Pointers to Preventing Hyperglycaemic Emergencies in Soweto. 42
Population-based Screening for Retinopathy: A Promising Start (Comment). 84
Potential for Reducing Health Care Costs by Public and Patient Education: Summary of Selected Studies. 300
Practical Community Screening for Retinopathy Using the Mobile Retinal Camera: Report of a 12 Centre Study. 84
Practice Guidelines for Nutrition Care by Dietetics Practitioners for Outpatients with Non-Insulin-Dependent Diabetes Mellitus: Consensus Statement. 240
Practice Guidelines for Nutrition Care by Dietetics Practitioners for Outpatients with Non-Insulin-Dependent Diabetes Mellitus: Methodologies for Field Testing and Cost-Effectiveness Analysis. 241
Precipitants of Hospitalization in Insulin-Dependent Diabetes Mellitus (IDDM): A Statewide Perspective. 154
Precision and Costs of Techniques for Self-Monitoring of Serum Glucose Levels. 43
Preventing Diabetic Foot Disease: Lessons From the Medicare Therapeutic Shoe Demonstration. 117
Prevention: The Cost-Effectiveness of the California Diabetes and Pregnancy Program. 137
Preventive Eye Care in People with Diabetes Is Cost-Saving to the Federal Government: Implications for Health Care Reform. 85
Preventive Health Services for Medicare Beneficiaries: Policy and Research Issues. 242
Preventive Services. 243
Profiling Overweight Patients in the U.S. Navy: Health Conditions and Costs. 222
A Prospective Evaluation of Transcutaneous Oxygen Measurements in the Management of Diabetic Foot Problems. 118
Prospective Reimbursement and Diabetes Mellitus: Impact Upon Glycemic Control and Utilization of Health Services. 186
Psychosocial Challenges for Children with Insulin-Dependent Diabetes Mellitus. 301
Public Cost and Access to Primary Care for Hyperglycemic Emergencies, Clark County, Nevada. 155
Public Health Focus: Physical Activity and the Prevention of Coronary Heart Disease. 244
Public Health Focus: Prevention of Blindness Associated with Retinopathy. 245
Quality Assurance Issues. 302
Quality-of-Life Evaluation in Diabetes. 303
Randomized Controlled Multicentre Evaluation of an Education Programme for Insulin-Treated Diabetic Patients: Effects on Metabolic Control, Quality of Life, and Costs of Therapy. 44
A Randomized Study of the Effects of a Home Diabetes Education Program. 62
Rationale for the Hypertension Guidelines for Primary Care in South Africa. 304
A RCT of Community Clinic Versus Hospital Outpatient Care in the Treatment of Non Insulin Dependent Diabetes Mellitus (NIDDM): Abstract. 187
Rediagnosing Health Care: Providers' Perspectives. 246
Reduced Hospital Utilization and Cost Savings Associated with Diabetes Patient Education. 63
Reimbursement for Diabetes Self-Care Training: The North Carolina Experience. 305
Reimbursement Issues in Diabetes. 306
Reins or Fences: A Physician's View of Cost Containment. 307
A Relative Cost-Effectiveness Analysis of Different Methods of Screening for Retinopathy. 86
Relative Risk and Economic Consequences of Inpatient Care Among Patients With Renal Failure. 156
Relevance of Postprandial Glycosuria in Survey for Diabetes Mellitus. 308
Reliability and Cost of Diabetic Diets. 50
Resource Manual to Help Your Program Meet the National Standards. 247
Resource Utilization and Costs of Care in the Diabetes Control and Complications Trial. 167
Resource Utilization in Treatment of Diabetic Ketoacidosis in Adults. 157
Retinopathy in the West of Scotland: Its Detection and Prevalence, and the Cost-Effectiveness of a Proposed Screening Programme. 87
Retinopathy — Need and Demand for Photocoagulation and Its Cost-Effectiveness: Evaluation Based on Services in the United Kingdom. 88
A Risk-Benefit Assessment of Conventional Versus Intensive Insulin Therapy. 45
Scientific Rigor of Economic Analyses (letter). 309
Screening for Diabetes Mellitus. 248
Screening for Diabetes Mellitus in General Practice Using a Reflectance Meter System: The Islington Diabetes Survey. 9
Screening for Gestational Diabetes. 128
Screening for Gestational Diabetes: An Analysis of Health Benefits and Costs. 130
Screening for Gestational Diabetes: Analysis by Screening Criteria. 129
Screening for Gestational Diabetes in a High-Risk Population. 131
Screening for Retinopathy. 310
Screening for Retinopathy: A Relative Cost-Effectiveness Analysis of Alternative Modalities and Strategies. 10
Screening for Retinopathy in a Clinical Setting: A Comparison of Direct Ophthalmoscopy by Primary Care Physicians with Fundus Photography. 89
Screening for Retinopathy in South Africa with 60° Retinal Colour Photography. 90
Screening of High-Risk and General Populations for Gestational Diabetes: Clinical Application and Cost Analysis. 132
Should Persons with Diabetes Be Licensed to Drive Trucks? Risk Management. 311
A Simple Economic Evaluation Model for Selecting Diabetes Health Care Strategies. 188
Simultaneous Pancreas-Kidney Transplantation (SPK): A Cost-Effectiveness Analysis Model (abstract). 104
Social and Economic Costs of Diabetes: An Estimate for 1979. 223
Social and Economic Impact on Youth-Onset Diabetes in Japan. 312
The Socio-Economic Cost of Diabetic Complications in France. 224
Source Book of Health Insurance Data 1991. 249
Spin-off Cost/Benefits of Expanded Nutritional Care. 51
Statistics, CPT, ICD-9, CDM, and Level III Codes: What Are They and How Did I Get This Job? 313
Structure and Costs of Health Care of Diabetic Patients in Finland. 225
Summary Document of Nutrition Intervention in Diabetes. 314
Systematic Care of Diabetic Patients in One General Practice: How Much Does It Cost? 226
Tallying the Cost Of Diabetes. 189
Targeted Screening for Diabetes in Community Chiropody Clinics. 11
Technical and Clinical Evaluation of Fructosamine Determination in Serum. 2
Therapeutic Interventions in the Progression of Diabetic Nephropathy. 105
Third Party Coverage for Diabetes Education Program. 250
Third Party Reimbursement for Diabetes Mellitus: Outpatient Education: A Year's Progress. 64
Third Party Reimbursement for Outpatient Diabetes Education and Counseling. 251
Towards Less Amputations in Diabetic Patients: Incidence, Causes, Cost, Treatment, and Prevention — A Review. 119
Trends in Medicare Reimbursement for End-Stage Renal Disease: 1974-1979. 190
Type I Diabetic Nephropathy: Clinical Characteristics and Economic Impact. 106
Use of Health Maintenance Organization Data Bases To Study Pharmacy Resource Usage in Diabetes Mellitus. 175
Use of Mobile Screening Unit for Retinopathy in Rural and Urban Areas. 91
Utility of Serum Fructosamine as a Measure of Glycemia in Young and Old Diabetic and Non-Diabetic Subjects. 46
Value of Serum Glucose Assay as Part of the Biochemical Profile in Screening for Diabetes. 12
Variation in Office-Based Quality: A Claims-Based Profile of Care Provided to Medicare Patients with Diabetes. 47
Weight Excess Before Pregnancy: Complications and Cost. 133
Where Do We Go From Here? 315
Where Have All the Pennies Gone? The Work of Manchester Medical Audit Advisory Group. 316
Why Do Elderly Diabetics Burden the Health Care System More Than Non-Diabetics? 191
Women with Diabetes During Pregnancy: Sociodemographics, Outcomes, and Costs of Care. 138
Worksheet to Estimate Program Costs and Savings. 252
Back to Economics of Diabetes Mellitus Indexes
Contact Us:
- CDC Diabetes Public Inquiries
- 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
8am-8pm ET
Monday-Friday
Closed Holidays - cdcinfo@cdc.gov
